Triple Combination Chemotherapy Effective For Advanced Colorectal Cancer, Trial Finds
Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval
Liver Transplants Extend Survival In Early-Stage Cancer
Trimodality Therapy Improves Survival In Early Disease
NCI Encourages IP Chemo For Stage III Ovarian Cancer
Study Finds No Evidence That Statins Cut Cancer Risk
Chest X-Ray Produces Many False-Positive Results
NMP22 Assay More Effective Than Conventional Lab Test
Chemotherapy After Surgery Extends Survival By 32%
Some Tumors Show Partial Response To Drug Combo
Recombinant TSH Avoids Need To Stop Replacement Therapy
Partial Responses To Zactima In Thyroid Cancer Trial
NCI-Approved Clinical Trials
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- Most Favored Nation drug pricing could put China on top
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line
